BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17074681)

  • 21. Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression.
    Ray D; Kwon SY; Tagoh H; Heidenreich O; Ptasinska A; Bonifer C
    Blood; 2013 Aug; 122(5):759-69. PubMed ID: 23616623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
    Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
    Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
    Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
    Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
    Heckman CA; Duan H; Garcia PB; Boxer LM
    Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
    Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
    Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
    Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
    Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
    Terstappen LW; Safford M; Könemann S; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1992 Jan; 6(1):70-80. PubMed ID: 1540262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
    Hess J; Nielsen PJ; Fischer KD; Bujard H; Wirth T
    Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis.
    Strobl H; Scheinecker C; Csmarits B; Majdic O; Knapp W
    Br J Haematol; 1995 Aug; 90(4):774-82. PubMed ID: 7669655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
    Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
    Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
    Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.